Quarterly Results- overall
Annual Results- Scale
Annual Results- Liquidity
Annual Results- Profitability/Return
Annual Results- Valuation
External Ecosystem
Sector
Major Subsidiaries/Associates
Key Clients
Products
Products
Product details
Operations
Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
|
Biocon Limited Expands Global Access to Affordable Medicines Through Biosimilars and Generics
Read More
|
|
Biocon ranks No. 13 in Science magazine's 2026 biopharma employer list
Read More
|
|
stock insights biocon share recovery syngene q2 results impact
Read More
|
|
Biocon Share Price Rises 2.97% Today: Price and Fundamentals
Read More
|
|
Biocon Secures Yesintek Market Entry Rights in Nine Additional Countries
Read More
|
|
Biocon expands global reach of Stelara biosimilar to nine more markets
Read More
|
|
Biocon gets additional global market entry for Yesintek to treat autoimmune diseases
Read More
|
|
Biocon Secures Market Entry for Yesintek™, a Proposed Biosimilar to Stelara®, in Additional Global Markets
Read More
|
|
Biocon Touches Rs 325.50 on Yesintek Entry in Nine Markets
Read More
|
|
Biocon: 'Yesintek' ???????????? ????? ?????????
Read More
|
|
Buy, Sell Or Hold: Kalyan Jewellers, Biocon, Paytm, Reliance Industries, ITC And IDFC First Bank — Ask Profit
Read More
|
|
News by CNBC TV18 on TradingView, 2026-10-26 — cnbctv:2b4fe5561094b:0
Read More
|
|
Biocon Succession Plan: Kiran Mazumdar-Shaw Names Claire Mazumdar As Future Leader
Read More
|
|
Bonus + Stock Splits + Dividends + Buybacks From June 29-July 3: Bajaj, M&M, Biocon, TechM; 46 Stocks In Focus
Read More
|
|
Natural Biocon (India) Ltd. Estimates – BSE:NATURAL
Read More
|
|
Biocon Q1 Review: Expect Growth In Second Half Of 2022, Says CEO Siddharth Mittal
Read More
|
|
Biocon Shares Fall After July-September Earnings
Read More
|
|
Biocon Claims Earliest Pertuzumab Launch Dates With Perjeta Settlement
Read More
|
|
Biocon inks global patent settlement pact with Genentech for breast cancer drug Pebrilzo
Read More
|
|
Biocon Secures Pebrilzo Launch Dates; Shares Fall 0.94%
Read More
|
|
Biocon settles licence agreement with Genetech for cancer treatment drug — Check earliest secured launch dates
Read More
|
|
Biocon settles patent dispute with Genentech over breast cancer drug
Read More
|
|
Biocon Settles Patent Dispute With Genentech; Shares Down
Read More
|
|
Biocon receives GST demand notice of over Rs 3.2 cr
Read More
|
|
Biocon Electric Files DRHP for IPO of Up to 59 Lakh Equity Shares
Read More
|
|
Upcoming IPO: Electrical products maker Biocon Electric files DRHP with SEBI
Read More
|